Zobrazeno 1 - 10
of 276
pro vyhledávání: '"Hiroo, Imai"'
Autor:
Yuki Kasahara, Ken Saijo, Reio Ueta, Ryunosuke Numakura, Keiju Sasaki, Yuya Yoshida, Sakura Taniguchi, Kota Ouchi, Keigo Komine, Hiroo Imai, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Pembrolizumab-containing regimens are the standard first-line treatment for recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC). The neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein-to-albumin ratio (CAR)
Externí odkaz:
https://doaj.org/article/cc8c325ec3a04e39996e022cf0c0c267
Autor:
Hiroo Imai, Ken Saijo, Noriko Takenaga, Keigo Komine, Kota Ouchi, Yuki Kasahara, Shiori Ishikawa, Keiju Sasaki, Yuya Yoshida, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka
Publikováno v:
Current Oncology, Vol 31, Iss 3, Pp 1477-1482 (2024)
Chylous ascites is a rare form of ascites with high triglyceride content arising from the thoracoabdominal lymph nodes in the peritoneal cavity due to various benign or malignant etiologies, including pancreatic cancer. During cancer chemotherapy, th
Externí odkaz:
https://doaj.org/article/83428e594a524abdbcf87492e97745fb
Autor:
Hiroo Imai, Yasuhiro Sakamoto, Shin Takahashi, Hiroyuki Shibata, Atsushi Sato, Kazunori Otsuka, Kenji Amagai, Masanobu Takahashi, Takuhiro Yamaguchi, Chikashi Ishioka
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-8 (2024)
Abstract Background Advanced pancreatic cancer is one of the leading causes of cancer-related deaths. For patients with advanced pancreatic cancer, gemcitabine and nanoparticle albumin-binding paclitaxel (nabPTX) combination (GEM/nabPTX) therapy is o
Externí odkaz:
https://doaj.org/article/5310443217344e7f9c587dac657eb026
Publikováno v:
Molecular Brain, Vol 16, Iss 1, Pp 1-9 (2023)
Abstract Cognitive functions depend on the time of day in various organisms. Previously, we found that 24-h recognition memory performance of nocturnal mice changes diurnally through SCOP protein-dependent regulation. It remains unknown whether diurn
Externí odkaz:
https://doaj.org/article/eed35dc86ad24b0083264ba91f5648b5
Publikováno v:
IBRO Neuroscience Reports, Vol 15, Iss , Pp S896- (2023)
Externí odkaz:
https://doaj.org/article/34bc63068871449aad23b40e21338d3f
Autor:
Ken Saijo, Hiroo Imai, Kota Ouchi, Keiju Sasaki, Yuya Yoshida, Yoshifumi Kawamura, Sakura Taniguchi, Yuki Kasahara, Keigo Komine, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundPembrolizumab-containing regimens are standards of care for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). The depth of response (DpR) predicts the survival of patients with several types of solid cancers; howev
Externí odkaz:
https://doaj.org/article/89de7cd621504bb1a0fcfb1d42f525ac
Autor:
Ken Saijo, Hiroo Imai, Hiromichi Katayama, Fumiyoshi Fujishima, Kenichi Nakamura, Yuki Kasahara, Kota Ouchi, Keigo Komine, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka
Publikováno v:
Case Reports in Oncology, Vol 15, Iss 2, Pp 762-769 (2022)
An 18-year-old Japanese man was diagnosed with an undifferentiated sarcoma of the spermatic cord, with multiple distant metastases to the lungs and bones. The patient received doxorubicin-based standard chemotherapy. Although the chemotherapy was eff
Externí odkaz:
https://doaj.org/article/e0afc7695b5349b09941760a4b7823ce
Autor:
Hiroo Imai, Akihisa Terakita
Publikováno v:
Biophysics and Physicobiology, Vol 20 (2023)
Externí odkaz:
https://doaj.org/article/12e19c0b9c8648c993ac880a537405f7
Autor:
Hiroo Imai, Hideki Kandori
Publikováno v:
Biophysics and Physicobiology, Vol 20 (2023)
Externí odkaz:
https://doaj.org/article/e9a31efb1e2b4013bd9d1a2b502b0f32
Autor:
Hiroo Imai, Hideki Kandori
Publikováno v:
Biophysics and Physicobiology, Vol 20 (2023)
Externí odkaz:
https://doaj.org/article/9ee5bd8256774cd4a3276cf4cdaea15e